Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H25N3O5S.3H2O |
Molecular Weight | 437.508 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
InChI
InChIKey=CTUAQTBUVLKNDJ-OBZXMJSBSA-N
InChI=1S/C17H25N3O5S.3H2O/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4;;;/h7-12,18,21H,5-6H2,1-4H3,(H,24,25);3*1H2/t7-,8-,9+,10+,11-,12-;;;/m1.../s1
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C17H25N3O5S |
Molecular Weight | 383.463 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:00 UTC 2023
by
admin
on
Fri Dec 15 16:16:00 UTC 2023
|
Record UNII |
FV9J3JU8B1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ01DH02
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
NCI_THESAURUS |
C260
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
NDF-RT |
N0000175496
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
WHO-ATC |
J01DH02
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
WHO-ATC |
J01DH52
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
FDA ORPHAN DRUG |
130799
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
||
|
LIVERTOX |
NBK547861
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
441129
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
DB00760
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
MEROPENEM
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
Meropenem
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
CHEMBL127
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
BB-52
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
FV9J3JU8B1
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
1392454
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
m7240
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB21617
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
DTXSID10274179
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
C059500
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
FV9J3JU8B1
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
759621
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
6770
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
1709
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
100000085626
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
29561
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | RxNorm | ||
|
43968
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
C1160
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY | |||
|
119478-56-7
Created by
admin on Fri Dec 15 16:16:01 UTC 2023 , Edited by admin on Fri Dec 15 16:16:01 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
ANHYDROUS->SOLVATE | |||
|
EXCRETED UNCHANGED |
Meropenem: approximately 40–60% of dose was excreted unchanged within 24 to 48 hours with a further 28% recovered as the microbiologically inactive hydrolysis product; fecal elimination accounts for ~2% of dose.
|
||
|
PARENT -> SALT/SOLVATE | |||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
correction factor: for the calculation of content, multiply the peak area of impurity A by 1.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||